Leads Patients Pharmaceutical research 
European Pharmaceutical Review
JUNE 15, 2023
A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. Importantly, they identify potential sources of microbial contamination and assess their risk to patients. Sharma et al.
European Pharmaceutical Review
AUGUST 15, 2023
“Fiera Milano is the ideal venue for a global event like CPHI, which is an important tenet of this industry and central to the world economy, with the Lombardy region being a leading producer of pharmaceuticals,” commented Roberto Foresti, deputy general manager of Fiera Milano.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
FEBRUARY 14, 2023
I look forward to applying my passion for science, experience in drug discovery and development and commitment to helping patients in leading the talented Pharmaceutical R&D team.” to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D.
Salesforce
JULY 12, 2021
Social distancing protocols spurred by the pandemic led to 76% of more than 200 clinical trial sponsors conducting most or all of their patient monitoring remotely. There’s a focus on increasing access to a broader, more diverse patient population. ” Power pharmaceutical research and development. Support innovation.
PharmaKinnex
AUGUST 23, 2022
From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients. – Increased Caution From Patients & Prescribers. – New & Updated Legislation.
Pharmaceutical Technology
FEBRUARY 13, 2023
However, there is a high level of attrition during the pharmaceutical research and development process, which is an indicator of the vast number of potential drug substances considered for progression. Therefore, it is vital to choose molecules for pharmaceutical development very carefully.
PM360
NOVEMBER 12, 2024
One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. Through the years, the one constant has been how leaders can collaborate and inspire great people working in teams to develop medicines that truly make a difference for patients.
Expert insights. Personalized for you.
103 
Let's personalize your content